Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat
- PMID: 2981427
- DOI: 10.1126/science.2981427
Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat
Abstract
Human T-cell leukemia virus type III (HTLV-III) was recently identified as the probable etiologic agent of the acquired immune deficiency syndrome (AIDS). Here it is shown that, in human T-cell lines infected with HTLV-III, gene expression directed by the long terminal repeat sequence of this virus is stimulated by more than two orders of magnitude compared to matched uninfected cells. The rate of transcription of the HTLV-III long terminal repeat is more than 1000 times that of the SV40 early promoter in one infected cell line. Thus, HTLV-III, like HTLV-I, HTLV-II, and the bovine leukemia virus, is characterized by trans-activation of transcription in infected cells. The efficiency of trans-activation in the case of HTLV-III may account, at least in part, for the virulent nature of HTLV-III infection.
Similar articles
-
Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.Proc Natl Acad Sci U S A. 1985 Apr;82(8):2277-81. doi: 10.1073/pnas.82.8.2277. Proc Natl Acad Sci U S A. 1985. PMID: 2986109 Free PMC article.
-
The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.Cell. 1985 Jul;41(3):813-23. doi: 10.1016/s0092-8674(85)80062-3. Cell. 1985. PMID: 2988790
-
Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors.J Virol. 1986 Mar;57(3):738-44. doi: 10.1128/JVI.57.3.738-744.1986. J Virol. 1986. PMID: 3005624 Free PMC article.
-
Molecular biology of human T-lymphotropic retroviruses.Cancer Res. 1985 Sep;45(9 Suppl):4539s-4544s. Cancer Res. 1985. PMID: 2990683 Review.
-
The comparative molecular biology of HTLV-I and HTLV-II.Princess Takamatsu Symp. 1984;15:177-85. Princess Takamatsu Symp. 1984. PMID: 6100637 Review.
Cited by
-
Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.Proc Natl Acad Sci U S A. 1989 Oct;86(19):7397-401. doi: 10.1073/pnas.86.19.7397. Proc Natl Acad Sci U S A. 1989. PMID: 2552444 Free PMC article.
-
Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat.J Virol. 1988 Jan;62(1):120-6. doi: 10.1128/JVI.62.1.120-126.1988. J Virol. 1988. PMID: 2824840 Free PMC article.
-
Dimerization of the tat protein from human immunodeficiency virus: a cysteine-rich peptide mimics the normal metal-linked dimer interface.Proc Natl Acad Sci U S A. 1988 Sep;85(17):6297-300. doi: 10.1073/pnas.85.17.6297. Proc Natl Acad Sci U S A. 1988. PMID: 2842763 Free PMC article.
-
Genetic regulation of human immunodeficiency virus.Microbiol Rev. 1991 Jun;55(2):193-205. doi: 10.1128/mr.55.2.193-205.1991. Microbiol Rev. 1991. PMID: 1886517 Free PMC article. Review.
-
Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein.Proc Natl Acad Sci U S A. 1988 Jun;85(12):4200-4. doi: 10.1073/pnas.85.12.4200. Proc Natl Acad Sci U S A. 1988. PMID: 2967970 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources